Background
Methods
Study design and population
Assessment of RNFL thickness
Definition of cardiovascular events
Ascertainment of covariates
Association validated in the GDES cohort
Ethics, consent, and permissions
Statistical analysis
Results
Baseline characteristics
Characteristics | Total | Tertile of mRNFL thickness | p-value | ||
---|---|---|---|---|---|
Highest | Middle | Lowest | |||
No. | 25,563 | 8495 | 8515 | 8553 | − |
Age, years | 55.25 (8.20) | 56.32 (8.17) | 55.11 (8.17) | 54.33 (8.15) | < 0.001 |
Female | 13,845 (54.2) | 4178 (49.2) | 4619 (54.3) | 5048 (59.0) | < 0.001 |
Ethnicity | < 0.001 | ||||
White | 23,199 (90.8) | 7534 (88.7) | 7730 (90.8) | 7935 (92.8) | |
Non-white | 2197 (8.6) | 899 (10.6) | 737 (8.7) | 561 (6.6) | |
Missing | 167 (0.7) | 62 (0.7) | 48 (0.6) | 57 (0.7) | |
Assessment center | < 0.001 | ||||
Sheffield | 7040 (27.5) | 2347 (27.6) | 2312 (27.2) | 2381 (27.8) | |
Liverpool | 1933 (7.6) | 648 (7.6) | 637 (7.5) | 648 (7.6) | |
Hounslow | 4738 (18.5) | 1698 (20.0) | 1599 (18.8) | 1441 (16.9) | |
Croydon | 6396 (25.0) | 1893 (22.3) | 2126 (25.0) | 2377 (27.8) | |
Birmingham | 5411 (21.2) | 1889 (22.2) | 1828 (21.5) | 1694 (19.8) | |
Swansea | 45 (0.2) | 20 (0.2) | 13 (0.2) | 12 (0.1) | |
Household income | < 0.001 | ||||
< £18,000 | 3964 (15.5) | 1468 (17.3) | 1283 (15.1) | 1213 (14.2) | |
£18,000–30,999 | 5258 (20.6) | 1886 (22.2) | 1744 (20.5) | 1628 (19.0) | |
£31,000–51,999 | 6101 (23.9) | 1963 (23.1) | 2034 (23.9) | 2140 (24.6) | |
£52,000–100,000 | 5323 (20.8) | 1572 (18.5) | 1845 (21.7) | 1906 (22.3) | |
> £100,000 | 1613 (6.3) | 473 (5.6) | 521 (6.1) | 619 (7.2) | |
Missing | 3304 (12.9) | 1133 (13.3) | 1088 (12.8) | 1083 (12.7) | |
Education level | < 0.001 | ||||
O levels, CSEs, GCSEs | 7408 (29.0) | 2728 (32.1) | 2460 (28.9) | 2220 (26.0) | |
A/AS levels | 1570 (6.1) | 485 (5.7) | 527 (6.2) | 558 (6.5) | |
Professional qualifications | 16,287 (63.7) | 5164 (60.8) | 5438 (63.9) | 5685 (66.5) | |
Missing | 298 (1.2) | 118 (1.4) | 90 (1.1) | 90 (1.1) | |
Townsend index | 0.002 | ||||
Least deprived quartile | 5372 (21.0) | 1715 (20.2) | 1801 (21.2) | 1856 (21.7) | |
Second quartile | 6013 (23.5) | 1913 (22.5) | 2066 (24.3) | 2034 (23.8) | |
Third quartile | 7160 (28.0) | 2412 (28.4) | 2399 (28.2) | 2349 (27.5) | |
Most deprived quartile | 6992 (27.4) | 2448 (28.8) | 2242 (26.3) | 2302 (26.9) | |
Missing | 26 (0.1) | 7 (0.08) | 7 (0.08) | 12 (0.1) | |
SBP, mmHg | 132.0 (17.7) | 133.6 (17.7) | 131.6 (17.5) | 130.7 (17.7) | < 0.001 |
DBP, mmHg | 79.82 (9.99) | 80.46 (9.95) | 79.58 (9.95) | 79.43 (10.04) | < 0.001 |
HbA1c, mmol/mol | 35.52 (5.86) | 35.95 (6.43) | 35.41 (5.56) | 35.20 (5.54) | < 0.001 |
Fasting glucose, mmol/L | 5.10 (0.95) | 5.15 (1.05) | 5.09 (0.89) | 5.07 (0.89) | < 0.001 |
Body mass index | < 0.001 | ||||
Normal | 8508 (33.3) | 2613 (30.8) | 2832 (33.3) | 3063 (35.8) | |
Overweight | 10,934 (42.8) | 3695 (43.5) | 3652 (42.9) | 3587 (41.9) | |
Obesity | 6002 (23.5) | 2138 (25.2) | 1994 (23.4) | 1870 (21.9) | |
Missing | 119 (0.5) | 49 (0.6) | 37 (0.4) | 33 (0.4) | |
Smoking status | 0.001 | ||||
Never | 8744 (34.2) | 2984 (35.1) | 2851 (33.5) | 2909 (34.0) | |
Ever/current | 2492 (9.8) | 896 (10.6) | 813 (9.6) | 783 (9.2) | |
Missing | 14,327 (56.1) | 4615 (54.3) | 4851 (57.0) | 4861 (56.8) | |
Drinking status | 0.002 | ||||
Never | 840 (3.3) | 289 (3.4) | 284 (3.3) | 267 (3.1) | |
Ever/current | 23,532 (92.1) | 7749 (91.2) | 7856 (92.3) | 7927 (92.7) | |
Missing | 1191 (4.7) | 457 (5.4) | 375 (4.4) | 359 (4.2) | |
MVPA | 0.042 | ||||
Least MVPA quartile | 5383 (21.1) | 1823 (21.5) | 1772 (20.8) | 1788 (20.9) | |
Second MVPA quartile | 5446 (21.3) | 1762 (20.7) | 1857 (21.8) | 1827 (21.4) | |
Third MVPA quartile | 5025 (19.7) | 1614 (19.0) | 1653 (19.4) | 1758 (20.6) | |
Most MVPA quartile | 5261 (20.6) | 1771 (20.9) | 1798 (21.1) | 1692 (19.8) | |
Missing | 4448 (17.4) | 1525 (18.0) | 1435 (16.9) | 1488 (17.4) | |
Hypertension at baseline | < 0.001 | ||||
No | 19,326 (75.6) | 6183 (72.8) | 6465 (75.9) | 6678 (78.1) | |
Yes | 6237 (24.4) | 2312 (27.2) | 2050 (24.1) | 1875 (21.9) | |
Diabetes at baseline | < 0.001 | ||||
No | 24,591 (96.2) | 8089 (95.2) | 8220 (96.5) | 8282 (96.8) | |
Yes | 972 (3.8) | 406 (4.8) | 295 (3.5) | 271 (3.2) | |
Antihypertension drug use | < 0.001 | ||||
No | 21,342 (83.5) | 6858 (80.7) | 7147 (83.9) | 7337 (85.8) | |
Yes | 4221 (16.5) | 1637 (19.3) | 1368 (16.1) | 1216 (14.2) | |
Insulin usage | 0.305 | ||||
No | 25,434 (99.5) | 8449 (99.5) | 8467 (99.4) | 8518 (99.6) | |
Yes | 129 (0.5) | 46 (0.5) | 48 (0.6) | 35 (0.4) | |
Lipid-lowering drug use | < 0.001 | ||||
No | 22,181 (86.8) | 7159 (84.3) | 7419 (87.1) | 7603 (88.9) | |
Yes | 3382 (13.2) | 1336 (15.7) | 1096 (12.9) | 950 (11.1) | |
SER, diopter | − 0.04 (1.90) | 0.31 (1.88) | 0.02 (1.80) | − 0.47 (1.93) | < 0.001 |
Intraocular pressure, mmHg | 15.19 (2.94) | 15.21 (2.97) | 15.12 (2.95) | 15.23 (2.89) | 0.027 |
Image quality score | 69.52 (8.68) | 68.80 (9.06) | 69.82 (8.60) | 69.94 (8.32) | < 0.001 |
Characteristics | Non-CVD group | CVD group | p value |
---|---|---|---|
No. | 24,282 | 1281 | - |
Age, years | 55.02 (8.20) | 59.59 (7.02) | < 0.001 |
Female | 13,388 (55.1) | 457 (35.7) | < 0.001 |
Ethnicity | 0.032 | ||
White | 22,013 (90.7) | 1186 (92.6) | |
Non-white | 2112 (8.7) | 85 (6.6) | |
Missing | 157 (0.7) | 10 (0.8) | |
Assessment center | <0.001 | ||
Sheffield | 6655 (27.4) | 385 (30.1) | |
Liverpool | 1827 (7.5) | 106 (8.3) | |
Hounslow | 4561 (18.8) | 177 (13.8) | |
Croydon | 6106 (25.2) | 290 (22.6) | |
Birmingham | 5091 (21.0) | 320 (25.0) | |
Swansea | 42 (0.2) | 3 (0.2) | |
Household income | < 0.001 | ||
< £18,000 | 3700 (15.2) | 264 (20.6) | |
£18,000–30,999 | 4971 (20.5) | 287 (22.4) | |
£31,000–51,999 | 5846 (24.1) | 255 (19.9) | |
£52,000–100,000 | 5111 (21.1) | 212 (16.6) | |
> £100,000 | 1555 (6.4) | 58 (4.5) | |
Missing | 3099 (12.8) | 205 (16.0) | |
Education qualification | < 0.001 | ||
O levels, CSEs, GCSEs | 6923 (28.5) | 485 (37.9) | |
A/AS levels | 1523 (6.3) | 47 (3.7) | |
Professional qualifications | 15,566 (64.1) | 721 (56.3) | |
Missing | 270 (1.1) | 28 (2.2) | |
Townsend deprivation index | 0.311 | ||
Least deprived quartile | 5077 (20.9) | 295 (23.0) | |
Second quartile | 5718 (23.6) | 295 (23.0) | |
Third quartile | 6805 (28.0) | 355 (27.7) | |
Most deprived quartile | 6656 (27.4) | 336 (26.2) | |
Missing | 26 (0.1) | 0 | |
Systolic blood pressure, mmHg | 131.60 (17.59) | 138.90 (18.05) | < 0.001 |
Diastolic blood pressure, mmHg | 79.69 (9.96) | 82.26 (10.38) | < 0.001 |
HbA1c, mmol/mol | 35.41 (5.67) | 37.53 (8.51) | < 0.001 |
Fasting glucose, mmol/L | 5.09 (0.92) | 5.26 (1.31) | < 0.001 |
Body mass index | < 0.001 | ||
Normal | 8234 (33.9) | 274 (21.4) | |
Overweight | 10,360 (42.7) | 574 (44.8) | |
Obesity | 5577 (23.0) | 425 (33.2) | |
Missing | 111 (0.5) | 8 (0.6) | |
Smoking status | < 0.001 | ||
Never | 8273 (34.1) | 471 (36.8) | |
Ever/current | 2301 (9.5) | 191 (14.9) | |
Missing | 13,708 (56.5) | 619 (48.3) | |
Drinking status | 0.622 | ||
Never | 792 (3.3) | 48 (3.8) | |
Ever/current | 22,360 (92.1) | 1172 (91.5) | |
Missing | 1130 (4.7) | 61 (4.8) | |
MVPA | < 0.001 | ||
Least MVPA quartile | 5078 (20.9) | 305 (23.8) | |
Second MVPA quartile | 5219 (21.5) | 227 (17.7) | |
Third MVPA quartile | 4807 (19.8) | 218 (17.0) | |
Most MVPA quartile | 5005 (20.6) | 256 (20.0) | |
Missing | 4173 (17.2) | 275 (21.5) | |
Hypertension at baseline | < 0.001 | ||
No | 18,566 (76.5) | 760 (59.3) | |
Yes | 5716 (23.5) | 521 (40.7) | |
Diabetes at baseline | < 0.001 | ||
No | 23,416 (96.4) | 1175 (91.7) | |
Yes | 866 (3.6) | 106 (8.3) | |
Antihypertension drug use | < 0.001 | ||
No | 20,441 (84.2) | 901 (70.3) | |
Yes | 3841 (15.8) | 380 (29.7) | |
Insulin usage | < 0.001 | ||
No | 24,175 (99.6) | 1259 (98.3) | |
Yes | 107 (0.4) | 22 (1.7) | |
Lipid-lowering drug use | < 0.001 | ||
No | 21,228 (87.4) | 953 (74.4) | |
Yes | 3054 (12.6) | 328 (25.6) | |
SER, diopter | − 0.06 (1.90) | 0.20 (1.90) | < 0.001 |
Intraocular pressure, mmHg | 15.18 (2.94) | 15.37 (2.90) | 0.024 |
Image quality score | 69.56 (8.67) | 68.63 (8.78) | < 0.001 |
Average mRNFL thickness (μm) | 28.55 (4.25) | 27.83 (4.16) | < 0.001 |
Association between mRNFL thickness and CVD events
RNFL thickness | Model 1 | Model 2 | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Per 5 μm decrease | 1.22 (1.14–1.31) | < 0.001 | 1.08 (1.01–1.17) | 0.033 |
Tertiles | ||||
Highest | Reference | − | Reference | − |
Second | 1.26 (1.10–1.46) | 0.001 | 1.16 (0.99–1.36) | 0.065 |
Lowest | 1.49 (1.30–1.70) | < 0.001 | 1.18 (1.01–1.38) | 0.036 |
P for trend | − | < 0.001 | − | 0.043 |